The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Subjects With Type 2 Diabetes. A 26-week, Randomised, Open-label, Active Comparator, Three-armed, Parallel-group, Multi-centre, Multinational Trial With a 52-week Extension
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Subjects With Type 2 Diabetes. A 26-week, Randomised, Open-label, Active Comparator, Three-armed, Parallel-group, Multi-centre, Multinational Trial With a 52-week Extension
This trial is conducted in Europe and North America. The aim of this trial is to compare the effect on blood sugar control of liraglutide or sitagliptin, both in combination with metformin, in subjects with type 2 diabetes inadequately controlled with metformin alone.
The trial has been extended by 52 weeks. The extension will consist of two 26-week periods:
Week 27-52 after randomisation
- All subjects will continue receiving sitagliptin or liraglutide at unchanged dose and dosing regimen.
Week 53-78 after randomisation
Inclusion Criteria:
Exclusion Criteria:
Caquas, 00725, Puerto Rico
Belgrade, 11000, Serbia and Montenegro
Nis, 18000, Serbia and Montenegro
Edgbaston, Birmingham, B15 2TH, United Kingdom